Spatial lipidomics reveals zone-specific hepatic lipid alteration and remodeling in Metabolic dysfunction-associated steatohepatitis.

Seubnooch, Patcharamon; Montani, Matteo; Dufour, Jean-François; Masoodi, Mojgan (2024). Spatial lipidomics reveals zone-specific hepatic lipid alteration and remodeling in Metabolic dysfunction-associated steatohepatitis. (In Press). Journal of lipid research, p. 100599. Elsevier 10.1016/j.jlr.2024.100599

[img]
Preview
Text
1-s2.0-S0022227524001044-main.pdf - Accepted Version
Available under License Creative Commons: Attribution (CC-BY).

Download (17MB) | Preview

Alteration in lipid metabolism plays a pivotal role in developing metabolic dysfunction-associated steatohepatitis (MASH). However, our understanding of alteration in lipid metabolism across liver zonation in MASH remains limited. Within this study, we investigated MASH-associated zone-specific lipid metabolism in a diet and chemical-induced MASH mouse model. Spatial lipidomics using mass spectrometry imaging in a MASH mouse model revealed 130 lipids from various classes altered across liver zonation and exhibited zone-specific lipid signatures in MASH. Triacylglycerols, diacylglycerols, sphingolipids and ceramides showed distinct zone-specific changes and re-distribution from pericentral to periportal localisation in MASH. Saturated and monounsaturated fatty acids (FA) were the primary FA composition of increased lipids in MASH, while polyunsaturated FAs were the major FA composition of decreased lipids. We observed elevated fibrosis in the periportal region, which could be the result of observed metabolic alteration across zonation. Our study provides valuable insights into zone-specific hepatic lipid metabolism and demonstrates the significance of spatial lipidomics in understanding liver lipid metabolism. Identifying unique lipid distribution patterns may offer valuable insights into the pathophysiology of MASH and facilitate the discovery of diagnostic markers associated with liver zonation.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Institute of Clinical Chemistry
04 Faculty of Medicine > Service Sector > Institute of Pathology > Clinical Pathology
04 Faculty of Medicine > Service Sector > Institute of Pathology
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hepatologie

Graduate School:

Graduate School for Cellular and Biomedical Sciences (GCB)

UniBE Contributor:

Seubnooch, Patcharamon, Montani, Matteo, Dufour, Jean-François

Subjects:

600 Technology > 610 Medicine & health
500 Science > 570 Life sciences; biology

ISSN:

1539-7262

Publisher:

Elsevier

Language:

English

Submitter:

Pubmed Import

Date Deposited:

22 Jul 2024 12:38

Last Modified:

23 Jul 2024 00:16

Publisher DOI:

10.1016/j.jlr.2024.100599

PubMed ID:

39032559

Uncontrolled Keywords:

Hepatic lipid zonation Lipid distribution Liver lipid metabolism Liver zonation MASH MASLD NAFLD NASH Steatotic liver disease

BORIS DOI:

10.48350/199125

URI:

https://boris.unibe.ch/id/eprint/199125

Actions (login required)

Edit item Edit item
Provide Feedback